Pros | ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Larger AUM within category. | ||
Cons | ![]() 5Y returns in the bottom 25% of the category. ![]() 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 2/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 5 Years | 6 Years | ||
Fund Size | 814 Cr | 5508 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 1.05% | 1.06% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 32 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (12.08%) Cipla Ltd (7.69%) Apollo Hospitals Enterprise Ltd (7.18%) Abbott India Ltd (6.09%) Torrent Pharmaceuticals Ltd (5.47%) | Sun Pharmaceuticals Industries Ltd (12.66%) Dr Reddy's Laboratories Ltd (9.66%) Divi's Laboratories Ltd (9.03%) Cipla Ltd (7.85%) Aurobindo Pharma Ltd (6.34%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (99.1%) Basic Materials (0.9%) | Health (94.88%) Basic Materials (3.81%) Financial Services (1.31%) | ||
Equity % | 97.94% | 96.99% | ||
Debt % | - | - | ||
P/E | 37.48 | 30.46 | ||
P/B | 6.13 | 4.13 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 1.88% | 1.49% | ||
3-Month Return | 4.55% | 7.77% | ||
6-Month Return | -2.98% | 0.05% | ||
1-Year Return | 15.15% | 23.69% | ||
3-Year Return | 24.98% | 30.57% | ||
5-Year Return | 20.99% | 25.42% |
Sharpe | 0.98 | 1.3 | ||
Alpha | -0.55 | 4.24 | ||
Beta | 0.96 | 0.95 | ||
Standard Deviation | 16.03 | 15.67 | ||
Information Ratio | -0.4 | 1.44 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Dharmesh Kakkad |